Health

FILE - In this Feb. 24, 2018, file photo, Department of Health and Human Services Secretary Alex Azar speaks at the National Governor Association 2018 winter meeting in Washington. The Trump administration is taking a pragmatic new track on health care with officials promising consumer-friendly changes and savings in areas from computerized medical records to prescription drugs. Azar has been rolling out the agenda, saying it has the full backing of President Donald Trump.(AP Photo/Jose Luis Magana, File)
March 12, 2018 - 12:10 am
WASHINGTON (AP) — A smartphone app that lets Medicare patients access their claims information. Giving consumers a share of drug company rebates for their prescriptions. Wider access to websites that reliably compare cost and quality of medical tests. The Trump administration is taking a pragmatic...
Read More
This undated product image provided by Sanofi shows Praluent 75 mg, a drug sold by Sanofi and Regeneron Pharmaceuticals. It’s one of a new class of cholesterol medicines that lower cholesterol far more than statin medicines can. A key study tested whether it also reduces heart attack risks and deaths. (Sanofi via AP)
March 10, 2018 - 10:40 am
ORLANDO, Fla. (AP) — A newer cholesterol drug, used with older statin medicines, modestly lowered heart risks and deaths in a big study of heart attack survivors that might persuade insurers to cover the pricey treatment more often. Results on the drug, Praluent (PRALL-yoo-ent), were announced...
Read More
This undated product image provided by Sanofi shows Praluent 75 mg, a drug sold by Sanofi and Regeneron Pharmaceuticals. It’s one of a new class of cholesterol medicines that lower cholesterol far more than statin medicines can. A key study tested whether it also reduces heart attack risks and deaths. (Sanofi via AP)
March 10, 2018 - 10:28 am
ORLANDO, Fla. (AP) — A newer cholesterol drug, used with older statin medicines, modestly lowered heart risks and deaths in a big study of heart attack survivors that might persuade insurers to cover the pricey treatment more often. Results on the drug, Praluent (PRALL-yoo-ent), were announced...
Read More
March 10, 2018 - 9:17 am
ORLANDO, Fla. (AP) — Heart attack survivors who can't tolerate or get enough help from cholesterol-lowering drugs called statins soon may have an easier time getting insurers to pay for a newer medicine that works in a different way. The drug, Praluent (PRALL-yoo-ent), modestly cut the risk of...
Read More
March 10, 2018 - 3:59 am
BEIJING (AP) — One of China's biggest cities has imposed curbs on traffic and factories due to a spike in air pollution and told elderly people and children to stay indoors. The government of Tianjin, a port city of 15.5 million people east of Beijing, said half its cars will be barred from the...
Read More
FILE - In this Aug. 15, 2017 photo, Martin Shkreli is interviewed on the Fox Business Network in New York. Shkreli cried in court Friday, March 9, 2018, as he apologized for defrauding investors while being sentenced by a federal judge. Prosecutors want him sentenced to 15 years in prison, while his defense attorney argued he only deserves 18 months because his investors in two failed hedge funds got their money back. (AP Photo/Richard Drew, File)
March 09, 2018 - 5:16 pm
NEW YORK (AP) — The smirk wiped off his face, a crying Martin Shkreli was sentenced to seven years in prison for securities fraud Friday in a hard fall for the pharmaceutical-industry bad boy vilified for jacking up the price of a lifesaving drug. Shkreli, the boyish-looking, 34-year-old...
Read More
FILE - In this Aug. 15, 2017 photo, Martin Shkreli is interviewed on the Fox Business Network in New York. Shkreli cried in court Friday, March 9, 2018, as he apologized for defrauding investors while being sentenced by a federal judge. Prosecutors want him sentenced to 15 years in prison, while his defense attorney argued he only deserves 18 months because his investors in two failed hedge funds got their money back. (AP Photo/Richard Drew, File)
March 09, 2018 - 4:40 pm
NEW YORK (AP) — The smirk wiped off his face, a crying Martin Shkreli was sentenced to seven years in prison for securities fraud Friday in a hard fall for the pharmaceutical-industry bad boy vilified for jacking up the price of a lifesaving drug. Shkreli, the boyish-looking, 34-year-old...
Read More
FILE - In this June 1, 2017, file photo, a sign stands on the campus of the Aetna headquarters, in Hartford, Conn. Insurers are dropping billions of dollars on acquisitions and expansions as they get more involved in their customers’ health. Late last year, CVS Health announced a roughly $69 billion deal to buy another insurer, Aetna. Those companies plan to convert drugstores into health care hotspots that people can turn to for a variety of needs in between doctor visits. (AP Photo/Bill Sikes, File)
March 09, 2018 - 4:07 pm
In the not-too-distant future, your health insurance, your prescription drugs and some of your treatment may come from the same company. Insurers are dropping billions of dollars on acquisitions and expansions in order to get more involved in customer health. They say this push can help cut costs...
Read More
FILE - In this Aug. 15, 2017 file photo, former pharmaceutical CEO Martin Shkreli speaks during an interview by Maria Bartiromo during her "Mornings with Maria Bartiromo" program on the Fox Business Network, in New York. Shkreli became notorious for raising the price of a life-saving drug by 5,000 percent and trolling critics on the internet with his snarky "Pharma Bro" persona. A federal judge in Brooklyn will have to weigh the conflicting portrayals of Shkreli on Friday, March 9, 2018, at his sentencing on a securities fraud conviction. (AP Photo/Richard Drew, File)
March 09, 2018 - 2:48 pm
NEW YORK (AP) — The Latest on the sentencing of "Pharma Bro" Martin Shkreli (all times local): 2:45 p.m. The attorney for convicted fraudster Martin Shkreli (SHKREL'-ee) says his client is doing "fine" after he was sentenced to seven years in prison. Ben Brafman had asked the judge for a sentence...
Read More
FILE - In this Aug. 15, 2017 file photo, former pharmaceutical CEO Martin Shkreli speaks during an interview by Maria Bartiromo during her "Mornings with Maria Bartiromo" program on the Fox Business Network, in New York. Shkreli became notorious for raising the price of a life-saving drug by 5,000 percent and trolling critics on the internet with his snarky "Pharma Bro" persona. A federal judge in Brooklyn will have to weigh the conflicting portrayals of Shkreli on Friday, March 9, 2018, at his sentencing on a securities fraud conviction. (AP Photo/Richard Drew, File)
March 09, 2018 - 2:09 pm
NEW YORK (AP) — Martin Shrkeli, the smirking "Pharma Bro" vilified for jacking up the price of a lifesaving drug, was sentenced Friday to seven years in prison for defrauding investors in two failed hedge funds. The self-promoting pharmaceutical executive notorious for trolling critics online was...
Read More

Pages